• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Perception of severity of adverse events in oral immunotherapy - Authors' reply.

作者信息

Chu Derek K, Wood Robert A, French Shannon, Fiocchi Alessandro, Waserman Susan, Schünemann Holger J

机构信息

Department of Medicine, St Joseph's Healthcare Hamilton, Hamilton, Ontario, ON, Canada; McMaster University, Hamilton, ON L8S 4K1, Canada.

Division of Allergy & Immunology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

出版信息

Lancet. 2020 Feb 8;395(10222):415-416. doi: 10.1016/S0140-6736(19)32567-X.

DOI:10.1016/S0140-6736(19)32567-X
PMID:32035550
Abstract
摘要

相似文献

1
Perception of severity of adverse events in oral immunotherapy - Authors' reply.口服免疫疗法中不良事件严重程度的认知——作者回复
Lancet. 2020 Feb 8;395(10222):415-416. doi: 10.1016/S0140-6736(19)32567-X.
2
Perception of severity of adverse events in oral immunotherapy.口服免疫疗法中不良事件严重程度的认知。
Lancet. 2020 Feb 8;395(10222):415. doi: 10.1016/S0140-6736(19)32491-2.
3
Editorial: the microscope holds the key to predict need for biologic therapy in immunotherapy-checkpoint inhibitory colitis. Authors' reply.
Aliment Pharmacol Ther. 2021 Mar;53(5):638-639. doi: 10.1111/apt.16245.
4
Patient selection for immunotherapy in head and neck cancer - Authors' reply.头颈部癌免疫治疗的患者选择——作者回复
Lancet Oncol. 2021 Jul;22(7):e291-e292. doi: 10.1016/S1470-2045(21)00339-9.
5
Reply to: "Mortality due to immunotherapy related hepatitis".
J Hepatol. 2018 Oct;69(4):978-979. doi: 10.1016/j.jhep.2018.07.009. Epub 2018 Aug 7.
6
Reply to: "Immune-related hepatitis with immunotherapy: Are corticosteroids always needed?".
J Hepatol. 2018 Aug;69(2):550-551. doi: 10.1016/j.jhep.2018.04.019.
7
The Latest Cancer Agents and Their Complications.最新的癌症治疗药物及其并发症。
Emerg Med Clin North Am. 2018 Aug;36(3):485-492. doi: 10.1016/j.emc.2018.04.006. Epub 2018 Jun 11.
8
Accounting for All Costs in the Total Cost of Chimeric Antigen Receptor T-Cell Immunotherapy-Reply.嵌合抗原受体T细胞免疫疗法总成本中的所有成本核算——回复
JAMA Oncol. 2018 Dec 1;4(12):1785-1786. doi: 10.1001/jamaoncol.2018.4657.
9
Reply to the Letter to the Editor: Reduced neuropsychiatric events as "beneficial reactions" to drugs: Seek associations with caution.致编辑信的回复：将减少的神经精神事件作为药物的“有益反应”：谨慎探寻关联。
Brain Behav Immun. 2020 Feb;84:277. doi: 10.1016/j.bbi.2019.11.012. Epub 2019 Nov 18.
10
Clarification of Definitions of Hyperprogressive Disease During Immunotherapy-Reply.免疫治疗期间超进展性疾病定义的澄清——回复
JAMA Oncol. 2021 Jan 1;7(1):137. doi: 10.1001/jamaoncol.2020.5591.